(Q44315582)

English

Sequential designs for phase III clinical trials incorporating treatment selection

scientific article published in March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sequential designs for phase III clinical trials incorporating treatment selection (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

phase III clinical trial

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

author name string

Susan Todd

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

0 references

publication date

1 March 2003

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Statistics in Medicine

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

689-703

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FSIM.1362

21 January 2018

Identifiers

10.1002/SIM.1362

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44315582&oldid=2109385011"